IL-33 shifts macrophage polarization, promoting resistance against Pseudomonas aeruginosa keratitis

Linda D Hazlett1, Sharon A McClellan, Ronald P Barrett

  • 1Department of Anatomy and Cell Biology, Wayne State University School of Medicine, Detroit, Michigan 48201, USA. lhazlett@med.wayne.edu

Abstract

Insights

Interleukin-33 (IL-33) enhances resistance to Pseudomonas aeruginosa keratitis by promoting a T-helper 2 (Th2) immune response. IL-33 also reduces inflammation through macrophage polarization, leading to anti-inflammatory mediator production in the cornea.

Area of Science:

  • Immunology
  • Ophthalmology
  • Microbiology

Background:

  • Pseudomonas aeruginosa keratitis is a serious eye infection.
  • The role of interleukin-33 (IL-33) in ocular defense against bacterial keratitis is not fully understood.
  • Understanding immune responses in keratitis is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the function of IL-33 in the context of Pseudomonas aeruginosa keratitis.
  • To determine if IL-33 influences disease severity and immune cell infiltration in the cornea.
  • To explore the impact of IL-33 on T-helper cell polarization and macrophage activity during infection.

Main Methods:

  • Compared IL-33 expression in susceptible (C57BL/6) and resistant (BALB/c) mice during infection.
  • Administered recombinant mouse IL-33 (rmIL-33) to susceptible mice to assess its effects on disease.
  • Analyzed bacterial load, immune cell infiltration (PMNs), cytokine profiles (RT-PCR), and macrophage polarization (immunostaining).

Main Results:

  • IL-33 levels were elevated in resistant mice post-infection.
  • rmIL-33 treatment in susceptible mice reduced disease severity, bacterial load, and PMN infiltration.
  • IL-33 promoted a T-helper 2 (Th2) cytokine profile (IL-4, IL-5, IL-10) and shifted macrophages towards an anti-inflammatory phenotype (arginase production).

Conclusions:

  • IL-33 plays a protective role in Pseudomonas aeruginosa keratitis.
  • IL-33 promotes Th2 immune responses and reduces corneal inflammation.
  • Macrophage polarization induced by IL-33 contributes to the anti-inflammatory effect.